Skip to content

Doctrine by topic · DGT Observatory

Medicines for Human Use: DGT doctrinal evolution

How the DGT's position on this topic has evolved, and the rulings it rests on.

← DGT Observatory

How the DGT's position has evolved

Settled doctrine High confidence 14 rulings · 2014–2026

Current position

Supplies, intra-Community acquisitions, and imports of products qualified as medicines for human use by the Spanish Agency of Medicines and Medical Devices are taxed at the reduced rate of 4%. If the product is not considered a medicine, the general rate of 21% applies, unless it is a pharmaceutical product from Chapter 30 of the Combined Nomenclature suitable for direct use by the final consumer, in which case it will be taxed at 10%.

The DGT's position remains constant regarding the distinction of tax rates according to the product's classification. The doctrine establishes that the status of being a medicine is the determining factor for applying the 4% rate, while the absence of such condition refers to the general rate or the 10% reduced rate for pharmaceutical products for direct use.

Analysis based on 14 of 14 rulings with a stated position. Updated 26 September 2026.

Rulings on this topic

14
V0292-26 12 Feb 2026

Face cosmetics deemed medicines subject to 4% VAT

SG de Impuestos sobre el Consumo
tipo impositivomedicamento de uso humanoestética facialadquisición intracomunitariaimportación LIVA — Ley 37/1992 del IVA art. 90LIVA — Ley 37/1992 del IVA art. 91.uno.1.6.a
Affects CompanyExpat · Non-residentIndividual
V0638-24 11 Apr 2024

VAT rate of 4% for medicinal products or 21% otherwise

SG de Impuestos sobre el Consumo
tipo reducidomedicamento de uso humanonomenclatura combinadauso directo por el consumidor finalproductos farmacéuticos LIVA — Ley 37/1992 del IVA art. 90LIVA — Ley 37/1992 del IVA art. 91.Uno.1.6.a
Affects CompanyExpat · Non-residentIndividual

Apply this to your case

Email
Contact